Loading...
Evidence that rifampicin can be used safely for non-tuberculous diseases.
The incidence of primary resistance to rifampicin in Mycobacterium tuberculosis has been analysed in countries where rifampicin is restricted to use for treating tuberculosis and in countries where its use is not restricted. There is no evidence that rifampicin-resistant M tuberculosis strains are m...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
1980
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC471381/ https://ncbi.nlm.nih.gov/pubmed/6781092 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|